Metropolitan Life Insurance Company (MetLife)’s Ormat Technologies ORA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,918
| Closed | -$193K | – | 1479 |
|
|
2024
Q1 | $193K | Sell |
2,918
-66
| -2% | -$4.41K | 0.01% | 733 |
|
|
2023
Q4 | $226K | Sell |
2,984
-93
| -3% | -$6.31K | 0.01% | 681 |
|
|
2023
Q3 | $215K | Buy |
3,077
+156
| +5% | +$12.1K | 0.01% | 643 |
|
|
2023
Q2 | $235K | Buy |
2,921
+101
| +4% | +$8.55K | 0.01% | 616 |
|
|
2023
Q1 | $239K | Sell |
2,820
-216
| -7% | -$18.9K | 0.01% | 604 |
|
|
2022
Q4 | $263K | Buy |
3,036
+281
| +10% | +$25.2K | 0.01% | 607 |
|
|
2022
Q3 | $237K | Hold |
2,755
| – | – | 0.01% | 619 |
|
|
2022
Q2 | $216K | Hold |
2,755
| – | – | 0.01% | 668 |
|
|
2022
Q1 | $225K | Sell |
2,755
-9,000
| -77% | -$659K | 0.01% | 763 |
|
|
2021
Q4 | $932K | Hold |
11,755
| – | – | 0.01% | 1018 |
|
|
2021
Q3 | $783K | Sell |
11,755
-709
| -6% | -$48.9K | 0.01% | 1141 |
|
|
2021
Q2 | $867K | Buy |
12,464
+789
| +7% | +$56.1K | 0.01% | 1124 |
|
|
2021
Q1 | $917K | Buy |
11,675
+632
| +6% | +$62.6K | 0.01% | 1007 |
|
|
2020
Q4 | $997K | Sell |
11,043
-878
| -7% | -$66.5K | 0.01% | 890 |
|
|
2020
Q3 | $705K | Sell |
11,921
-188
| -2% | -$11.3K | 0.01% | 962 |
|
|
2020
Q2 | $769K | Buy |
12,109
+14
| +0.1% | +$916 | 0.01% | 902 |
|
|
2020
Q1 | $818K | Sell |
12,095
-506
| -4% | -$38.2K | 0.02% | 786 |
|
|
2019
Q4 | $939K | Sell |
12,601
-250
| -2% | -$18.9K | 0.02% | 927 |
|
|
2019
Q3 | $955K | Buy |
12,851
+673
| +6% | +$46.4K | 0.02% | 882 |
|
|
2019
Q2 | $772K | Hold |
12,178
| – | – | 0.01% | 1044 |
|
|
2019
Q1 | $672K | Hold |
12,178
| – | – | 0.01% | 1116 |
|
|
2018
Q4 | $637K | Sell |
12,178
-920
| -7% | -$48.4K | 0.01% | 1060 |
|
|
2018
Q3 | $709K | Hold |
13,098
| – | – | 0.01% | 1129 |
|
|
2018
Q2 | $697K | Hold |
13,098
| – | – | 0.01% | 1105 |
|
|
2018
Q1 | $738K | Buy |
13,098
+234
| +2% | +$14.6K | 0.01% | 1048 |
|
|
2017
Q4 | $823K | Sell |
12,864
-14,233
| -53% | -$903K | 0.01% | 1001 |
|
|
2017
Q3 | $1.65M | Hold |
27,097
| – | – | 0.01% | 1006 |
|
|
2017
Q2 | $1.59M | Buy |
27,097
+136
| +0.5% | +$7.98K | 0.01% | 1031 |
|
|
2017
Q1 | $1.54M | Sell |
26,961
-267
| -1% | -$14.8K | 0.01% | 1052 |
|
|
2016
Q4 | $1.46M | Sell |
27,228
-560
| -2% | -$27.2K | 0.01% | 1094 |
|
|
2016
Q3 | $1.34M | Hold |
27,788
| – | – | 0.01% | 1132 |
|
|
2016
Q2 | $1.22M | Sell |
27,788
-244
| -0.9% | -$10.4K | 0.01% | 1147 |
|
|
2016
Q1 | $1.16M | Buy |
28,032
+345
| +1% | +$12.8K | 0.01% | 1105 |
|
|
2015
Q4 | $1.01M | Buy |
27,687
+2,426
| +10% | +$88.4K | 0.01% | 1183 |
|
|
2015
Q3 | $860K | Hold |
25,261
| – | – | 0.01% | 1277 |
|
|
2015
Q2 | $952K | Sell |
25,261
-883
| -3% | -$33.2K | 0.01% | 1324 |
|
|
2015
Q1 | $994K | Buy |
26,144
+11,715
| +81% | +$368K | 0.01% | 1197 |
|
|
2014
Q4 | $392K | Hold |
14,429
| – | – | ﹤0.01% | 1935 |
|
|
2014
Q3 | $379K | Hold |
14,429
| – | – | ﹤0.01% | 1903 |
|
|
2014
Q2 | $416K | Sell |
14,429
-328
| -2% | -$9.32K | ﹤0.01% | 1972 |
|
|
2014
Q1 | $443K | Hold |
14,757
| – | – | ﹤0.01% | 1895 |
|
|
2013
Q4 | $402K | Hold |
14,757
| – | – | ﹤0.01% | 1965 |
|
|
2013
Q3 | $395K | Hold |
14,757
| – | – | ﹤0.01% | 1925 |
|
|
2013
Q2 | $347K | Buy |
+14,757
| New | +$327K | ﹤0.01% | 1941 |
|
Other funds holding ORA
OC
GACM
CI
Metropolitan Life Insurance Company (MetLife)'s ORA Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Ormat Technologies (ORA) in Q2 2024, closing a stake of 2,918 shares — an estimated $193K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ORA in Q2 2013 and held it in 44 quarters. The position peaked at $1.65M in Q3 2017. 280 funds tracked by Wall St. Rank hold ORA as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Ormat Technologies position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,918 Ormat Technologies shares in Q2 2024, an estimated $193K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Ormat Technologies in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Ormat Technologies position peaked at $1.65M in Q3 2017.
- 280 funds tracked by Wall St. Rank held Ormat Technologies as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.